Clinical trial
Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs…
NCT00238992 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00238992 |
|---|---|
| Title | Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients. |
| Official title | A Prospective, Randomized, Open Label, Multicenter Trial of EC-MPS With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen for the Prevention of Acute Rejection Episodes in de Novo Renal Transplant Recipients. |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney de Novo Transplant |
| Intervention type | Drug |
| Interventions | Enteric-coated Mycophenolate sodium (EC-MPS) |
| Enrollment | 144 |
| Start date | Dec 1, 2002 |
| Primary completion | Jul 1, 2005 |
| First posted | Oct 14, 2005 |
| Last update posted | Nov 2, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: